Pure Bioscience (PURE) 1.0300 $PURE
PURE Bioscience Reports 2016 Fiscal Third Quarter and Nine-Month Financial Results
BusinessWire - Thu Jun 09, 3:01PM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal third quarter and nine-month periods ended April 30, 2016.
OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference
PR Newswire - Tue May 31, 5:49PM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the Marcum MicroCap Conference, taking place June 1-2nd at the Grand Hyatt New York. The Marcum MicroCap Conference, is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The Conference will feature presentations by CEOs and CFOs from various industry sectors, expert panels, and the opportunity to meet with management of presenting companies on a one-on-one basis.
PURE Bioscience Raises $1.27 Million from Warrant Exercise
BusinessWire - Tue May 24, 7:41AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that the Company raised $1.27 million from the recent exercise by all of the holders of the 2,820,670 warrants expiring May 23, 2016.
PURE Bioscience Sets Q3 Results Conference Call to Update Progress of FDA Approved PURE Control(R) Antimicrobial and the Company's Food Safety Solutions Strategy
BusinessWire - Tue May 24, 7:36AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that on June 9, 2016 the Company will file its Form 10-Q shortly after the close of the market and host an investor conference call that day at 1:30pm PDT (4:30pm EDT) to review fiscal third quarter financial results.
PURE Bioscience to Present at the 2016 Marcum MicroCap Conference on June 2nd
BusinessWire - Wed May 18, 7:36AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today the Company will present at the 2016 Marcum MicroCap Conference at 11:30am EDT on Thursday, June 2, 2016 in New York City at the Grand Hyatt Hotel.
PURE Bioscience to Present at the Joseph Gunnar "Pioneers 2016" Conference on May 5th
BusinessWire - Thu Apr 21, 7:36AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today the Company will present at the Joseph Gunnar "Pioneers 2016" Conference on May 5, 2016 at the Palace Hotel in New York City.
UPDATE -- OTCQX and OTCQB Companies to Present at 2016 Roth Conference
PR Newswire - Mon Mar 14, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the 28th Annual ROTH Conference, taking place March 13-16 at the Ritz-Carlton in Dana Point, CA. The ROTH Conference, hosted by ROTH Capital Partners, LLC, is one of the largest small-cap investment conferences in the U.S., featuring presentations by senior executives from hundreds of public and private companies in a wide variety of sectors.
VRAY: 4.79 (-0.06), CDXC: 5.49 (-0.18)
OTCQX And OTCQB Companies To Present At 2016 ROTH Conference
PR Newswire - Thu Mar 10, 6:00AM CST
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the 28th Annual ROTH Conference, taking place March 13-16 at the Ritz-Carlton in Dana Point, CA. The ROTH Conference, hosted by ROTH Capital Partners, LLC, is one of the largest small-cap investment conferences in the U.S., featuring presentations by senior executives from hundreds of public and private companies in a wide variety of sectors.
VRAY: 4.79 (-0.06), CDXC: 5.49 (-0.18)
PURE Bioscience Reports 2016 Fiscal Second Quarter and Six-Month Financial Results
BusinessWire - Wed Mar 09, 3:02PM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal second quarter and six-month periods ended January 31, 2016.
Moving Ahead of Averages, Technical Review -- Research on Saleen Automotive, Cherubim Interests, Fission Uranium, and Pure Biosciences
ACCESSWIRE - Mon Feb 01, 8:00AM CST
NEW YORK, NY / ACCESSWIRE / February 1, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Saleen Automotive Inc. (OTC: SLNN), Cherubim Interests Inc. (OTC: CHIT), Fission Uranium Corp. (OTC: FCUUF) and Pure Biosciences Inc. (OTC: PURE). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
PURE Bioscience Unveiled PURE Control(R) at 2016 IPPE in Atlanta, GA
Marketwired - Mon Feb 01, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the FDA approved, patented silver dihydrogen citrate (SDC) antimicrobial, announced that the Company introduced PURE Control(R) at IPPE (International Production & Processing Expo) last week. IPPE is the world's largest annual poultry, meat and feed industry event attended by more than 30,000 industry leaders and their suppliers seeking to learn about the latest technological developments in the industry.
New Information Reveals Opportunity in Volatility -- Featured Research on Norsk Hydro, Paragon Offshore, Pure Biosciences and Cocrystal Pharma
ACCESSWIRE - Thu Jan 14, 7:46AM CST
NEW YORK, NY / ACCESSWIRE / January 14, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Norsk Hydro ASA (OTC: NHYDY), Paragon Offshore Plc. (OTC: PGNPF), Pure Biosciences Inc. (OTC: PURE) and Cocrystal Pharma Inc. (OTC: COCP). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
PURE Bioscience to Present at the Noble Financial 12th Annual Emerging Growth Investor Conference
BusinessWire - Mon Jan 11, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the FDA approved, patented silver dihydrogen citrate (SDC) antimicrobial, announced today the Company will present at the Noble Financial "NobleCon12" Investment Conference on January 19th 2016 in Florida.
PURE Bioscience's PURE(R) Hard Surface Disinfectant -- Revolutionizing Restaurant Chain Food Safety With Superior Effective Solution to Foodborne Illness
Marketwired - Fri Jan 08, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today discussed its best-in-class food safety solutions for eliminating pathogens in restaurant operations, including Norovirus, E. coli, Salmonella and Listeria. PURE's recent traction in its sales and marketing outreach to restaurant chains highlights the proven superior safety and efficacy of the PURE Total Solution: SDC-based PURE(R) Hard Surface food contact surface disinfectant plus recently FDA approved PURE Control(R) (for use directly on fresh produce or raw poultry during processing).
PURE Bioscience passes US FDA approval for use of SDC antimicrobial as fresh produce processing aid
M2 - Wed Jan 06, 5:41AM CST
Antimicrobial company PURE Bioscience (OTCQB
URE) revealed on Tuesday the successful US FDA review of the safety and efficacy of the proposed use of silver dihydrogen citrate (SDC) based PURE Control as a fresh produce processing aid to combat foodborne illness and reduce pathogens, including Salmonella, E. coli and Listeria.
PURE Bioscience Receives FDA Approval for Use of SDC Antimicrobial as Fresh Produce Processing Aid to Combat Foodborne Illness and Reduce Pathogens, Including Salmonella, E. coli and Listeria
Marketwired - Tue Jan 05, 7:38AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the EPA and FDA approved, patented silver dihydrogen citrate (SDC) antimicrobial, today announced that the FDA has completed its review of the safety and efficacy of the proposed use of silver dihydrogen citrate (SDC) as a fresh produce processing aid and declared PURE Bioscience's food contact notification (FCN) to be effective as of January 7, 2016. SDC is the active ingredient in PURE Control(R).
PURE Bioscience Receives FDA Approval for Use of SDC Antimicrobial as Poultry Processing Aid to Reduce Pathogens, Including Salmonella
BusinessWire - Fri Dec 18, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that the FDA has completed its review of the safety and efficacy of the proposed use of silver dihydrogen citrate (SDC) as a raw poultry processing aid and declared PURE Bioscience's food contact notification (FCN) to be effective as of December 18, 2015.
PURE Bioscience Reports 2016 Fiscal First Quarter Financial Results
Marketwired - Thu Dec 10, 3:02PM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2015.
PURE Bioscience Hosts Fiscal 2016 Q1 Results Conference Call to Discuss Pending FDA Approvals and Go to Market Plans for PURE Control(R)
Marketwired - Mon Nov 30, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that the Company will host an investor conference call on December 10, 2015 at 1:30pm PST (4:30pm EST) to review fiscal 2016 Q1 results.
PURE's SDC Antimicrobial is a Featured Listeria Solution in Food Safety Consortium Presentation by James Marsden, Ph.D.
BusinessWire - Fri Nov 20, 7:36AM CST
--Attended by Food Safety Industry Experts and Government Officials
PURE Bioscience Reports 2016 Fiscal Third Quarter and Nine-Month Financial Results
BusinessWire - Thu Jun 09, 3:01PM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal third quarter and nine-month periods ended April 30, 2016.
OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference
PR Newswire - Tue May 31, 5:49PM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the Marcum MicroCap Conference, taking place June 1-2nd at the Grand Hyatt New York. The Marcum MicroCap Conference, is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The Conference will feature presentations by CEOs and CFOs from various industry sectors, expert panels, and the opportunity to meet with management of presenting companies on a one-on-one basis.
PURE Bioscience Raises $1.27 Million from Warrant Exercise
BusinessWire - Tue May 24, 7:41AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that the Company raised $1.27 million from the recent exercise by all of the holders of the 2,820,670 warrants expiring May 23, 2016.
PURE Bioscience Sets Q3 Results Conference Call to Update Progress of FDA Approved PURE Control(R) Antimicrobial and the Company's Food Safety Solutions Strategy
BusinessWire - Tue May 24, 7:36AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that on June 9, 2016 the Company will file its Form 10-Q shortly after the close of the market and host an investor conference call that day at 1:30pm PDT (4:30pm EDT) to review fiscal third quarter financial results.
PURE Bioscience to Present at the 2016 Marcum MicroCap Conference on June 2nd
BusinessWire - Wed May 18, 7:36AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today the Company will present at the 2016 Marcum MicroCap Conference at 11:30am EDT on Thursday, June 2, 2016 in New York City at the Grand Hyatt Hotel.
PURE Bioscience to Present at the Joseph Gunnar "Pioneers 2016" Conference on May 5th
BusinessWire - Thu Apr 21, 7:36AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today the Company will present at the Joseph Gunnar "Pioneers 2016" Conference on May 5, 2016 at the Palace Hotel in New York City.
UPDATE -- OTCQX and OTCQB Companies to Present at 2016 Roth Conference
PR Newswire - Mon Mar 14, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the 28th Annual ROTH Conference, taking place March 13-16 at the Ritz-Carlton in Dana Point, CA. The ROTH Conference, hosted by ROTH Capital Partners, LLC, is one of the largest small-cap investment conferences in the U.S., featuring presentations by senior executives from hundreds of public and private companies in a wide variety of sectors.
VRAY: 4.79 (-0.06), CDXC: 5.49 (-0.18)
OTCQX And OTCQB Companies To Present At 2016 ROTH Conference
PR Newswire - Thu Mar 10, 6:00AM CST
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the 28th Annual ROTH Conference, taking place March 13-16 at the Ritz-Carlton in Dana Point, CA. The ROTH Conference, hosted by ROTH Capital Partners, LLC, is one of the largest small-cap investment conferences in the U.S., featuring presentations by senior executives from hundreds of public and private companies in a wide variety of sectors.
VRAY: 4.79 (-0.06), CDXC: 5.49 (-0.18)
PURE Bioscience Reports 2016 Fiscal Second Quarter and Six-Month Financial Results
BusinessWire - Wed Mar 09, 3:02PM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal second quarter and six-month periods ended January 31, 2016.
Moving Ahead of Averages, Technical Review -- Research on Saleen Automotive, Cherubim Interests, Fission Uranium, and Pure Biosciences
ACCESSWIRE - Mon Feb 01, 8:00AM CST
NEW YORK, NY / ACCESSWIRE / February 1, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Saleen Automotive Inc. (OTC: SLNN), Cherubim Interests Inc. (OTC: CHIT), Fission Uranium Corp. (OTC: FCUUF) and Pure Biosciences Inc. (OTC: PURE). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
PURE Bioscience Unveiled PURE Control(R) at 2016 IPPE in Atlanta, GA
Marketwired - Mon Feb 01, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the FDA approved, patented silver dihydrogen citrate (SDC) antimicrobial, announced that the Company introduced PURE Control(R) at IPPE (International Production & Processing Expo) last week. IPPE is the world's largest annual poultry, meat and feed industry event attended by more than 30,000 industry leaders and their suppliers seeking to learn about the latest technological developments in the industry.
New Information Reveals Opportunity in Volatility -- Featured Research on Norsk Hydro, Paragon Offshore, Pure Biosciences and Cocrystal Pharma
ACCESSWIRE - Thu Jan 14, 7:46AM CST
NEW YORK, NY / ACCESSWIRE / January 14, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Norsk Hydro ASA (OTC: NHYDY), Paragon Offshore Plc. (OTC: PGNPF), Pure Biosciences Inc. (OTC: PURE) and Cocrystal Pharma Inc. (OTC: COCP). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
PURE Bioscience to Present at the Noble Financial 12th Annual Emerging Growth Investor Conference
BusinessWire - Mon Jan 11, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the FDA approved, patented silver dihydrogen citrate (SDC) antimicrobial, announced today the Company will present at the Noble Financial "NobleCon12" Investment Conference on January 19th 2016 in Florida.
PURE Bioscience's PURE(R) Hard Surface Disinfectant -- Revolutionizing Restaurant Chain Food Safety With Superior Effective Solution to Foodborne Illness
Marketwired - Fri Jan 08, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today discussed its best-in-class food safety solutions for eliminating pathogens in restaurant operations, including Norovirus, E. coli, Salmonella and Listeria. PURE's recent traction in its sales and marketing outreach to restaurant chains highlights the proven superior safety and efficacy of the PURE Total Solution: SDC-based PURE(R) Hard Surface food contact surface disinfectant plus recently FDA approved PURE Control(R) (for use directly on fresh produce or raw poultry during processing).
PURE Bioscience passes US FDA approval for use of SDC antimicrobial as fresh produce processing aid
M2 - Wed Jan 06, 5:41AM CST
Antimicrobial company PURE Bioscience (OTCQB
URE) revealed on Tuesday the successful US FDA review of the safety and efficacy of the proposed use of silver dihydrogen citrate (SDC) based PURE Control as a fresh produce processing aid to combat foodborne illness and reduce pathogens, including Salmonella, E. coli and Listeria. PURE Bioscience Receives FDA Approval for Use of SDC Antimicrobial as Fresh Produce Processing Aid to Combat Foodborne Illness and Reduce Pathogens, Including Salmonella, E. coli and Listeria
Marketwired - Tue Jan 05, 7:38AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the EPA and FDA approved, patented silver dihydrogen citrate (SDC) antimicrobial, today announced that the FDA has completed its review of the safety and efficacy of the proposed use of silver dihydrogen citrate (SDC) as a fresh produce processing aid and declared PURE Bioscience's food contact notification (FCN) to be effective as of January 7, 2016. SDC is the active ingredient in PURE Control(R).
PURE Bioscience Receives FDA Approval for Use of SDC Antimicrobial as Poultry Processing Aid to Reduce Pathogens, Including Salmonella
BusinessWire - Fri Dec 18, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that the FDA has completed its review of the safety and efficacy of the proposed use of silver dihydrogen citrate (SDC) as a raw poultry processing aid and declared PURE Bioscience's food contact notification (FCN) to be effective as of December 18, 2015.
PURE Bioscience Reports 2016 Fiscal First Quarter Financial Results
Marketwired - Thu Dec 10, 3:02PM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2015.
PURE Bioscience Hosts Fiscal 2016 Q1 Results Conference Call to Discuss Pending FDA Approvals and Go to Market Plans for PURE Control(R)
Marketwired - Mon Nov 30, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that the Company will host an investor conference call on December 10, 2015 at 1:30pm PST (4:30pm EST) to review fiscal 2016 Q1 results.
PURE's SDC Antimicrobial is a Featured Listeria Solution in Food Safety Consortium Presentation by James Marsden, Ph.D.
BusinessWire - Fri Nov 20, 7:36AM CST
--Attended by Food Safety Industry Experts and Government Officials
